Phillip Gomez, Siga Technologies CEO
Siga nabs $10.7M from the US government in deal for its monkeypox antiviral
The US government is all set to buy $10.7 million worth of Siga Technologies’ monkeypox oral antiviral, the company announced Thursday.
Of the total doses …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.